CELH
Overvalued by 44.4% based on the discounted cash flow analysis.
Market cap | $9.48 Billion |
---|---|
Enterprise Value | $8.56 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.62 |
Beta | 1.63 |
Outstanding Shares | 235,191,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 59.71 |
---|---|
PEG | -67.78 |
Price to Sales | 7.88 |
Price to Book Ratio | 7.88 |
Enterprise Value to Revenue | 6.24 |
Enterprise Value to EBIT | 37.05 |
Enterprise Value to Net Income | 41 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.13 |
No data
No data
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...